Infectious Disease Physician Salary Guide 2026: ID Doctor Pay, OPAT Revenue & Stewardship

Infectious disease (ID) physicians manage some of the most clinically complex cases in medicine — multidrug-resistant organisms, HIV, transplant infection prophylaxis, fungal and parasitic infections, and pandemic response — while consistently ranking at or near the bottom of physician specialty compensation surveys. The IDSA has documented that ID physicians generate fewer wRVUs than most internal medicine subspecialties relative to their training and clinical complexity, largely because ID care is consultation-heavy, time-intensive for counseling and stewardship, and poorly reimbursed by E&M codes relative to procedural specialties. In 2026, employed ID physician compensation ranges from $230,000–$320,000, with private practice OPAT infusion models and pharmaceutical industry positions offering meaningfully higher ceilings. This guide covers the full compensation landscape including OPAT revenue, stewardship stipends, HIV clinic pay, and the loan repayment options that make ID compensation more competitive in shortage-area markets.

Infectious disease physician salary by setting

• Employed ID physician (health system): $230,000–$320,000; salary + productivity bonus; predominantly inpatient consultation-based income with outpatient ID clinic; health systems increasingly recognizing the stewardship value and add-on stipend income to retain ID talent; most common employment model
• Private practice ID with OPAT infusion center: $255,000–$360,000; the income premium over employed is driven by outpatient parenteral antimicrobial therapy (OPAT) infusion center revenue; ID practices managing IV antibiotics in office (for osteomyelitis, endocarditis, septic arthritis, complicated skin/soft tissue infections) can generate meaningful J-code billing on top of E&M income
• Academic infectious disease (medical school faculty): $200,000–$275,000; lowest nominal pay in most markets; offset substantially by NIH R01/K-series grant funding for researchers (HIV, antimicrobial resistance, viral hepatitis, global health); significant protected research time; clinical fellowship training program direction adds academic leadership compensation in some programs
• HIV specialist / Ryan White-funded clinic: $200,000–$270,000; HIV primary care, ART management, pre-exposure prophylaxis (PrEP), and sexual health; Ryan White program funding supplements clinical revenue in underserved HIV care settings; NHSC loan repayment available for ID physicians at qualifying sites
• Travel medicine / tropical infectious disease: $210,000–$285,000; travel medicine clinic, pre-travel vaccination, tropical disease diagnosis; often combined with general ID practice; direct-pay vaccine revenue supplements insurance-based income
• Pharmaceutical / biotech medical affairs: $250,000–$400,000 base + significant bonus and equity; medical director and medical affairs roles at antibiotic developers, antiviral companies, and vaccine manufacturers; MSL (medical science liaison) leadership; advisory board compensation
• Epidemiology / public health hybrid: $180,000–$260,000; state health department, CDC, WHO, or USAID-aligned roles; lower base than clinical practice but non-clinical mission alignment; significant international travel for outbreak response positions

OPAT infusion revenue and private ID practice

Outpatient parenteral antimicrobial therapy (OPAT) infusion is the most significant income differentiator between employed health system ID physicians and independent private practice ID physicians:

• How OPAT practice works: ID practices with in-office or affiliated infusion center capability manage patients who need IV antibiotics after hospital discharge — osteomyelitis, prosthetic joint infections, endocarditis, MRSA bacteremia, invasive fungal infections; the infusion center bills both the drug (via J-code) and the administration/nursing services
• Drug margin: IV antibiotics under buy-and-bill (ceftriaxone, vancomycin, daptomycin, ertapenem, antifungals like micafungin and voriconazole) are purchased at ASP and billed at ASP + markup; high-volume OPAT practices can generate $100,000–$300,000+ in annual drug margin
• Clinical management codes: OPAT patients are managed with ID clinic visits during their course; E&M billing for OPAT oversight adds to total professional fee income
• Care coordination complexity: OPAT requires weekly labs, PICC line management, pharmacy coordination, and patient education — the clinical overhead is real, and smaller ID practices often partner with home infusion companies rather than operating fully self-contained OPAT programs

Antimicrobial stewardship program (ASP) stipend income

Joint Commission and CMS requirements for antimicrobial stewardship at accredited hospitals have created a structured source of supplemental income for ID physicians who take on ASP leadership roles:

• ASP Medical Director stipend: $15,000–$40,000/year; typical range at community hospitals and regional health systems; ID physician provides programmatic oversight, antibiogram review, restriction policy development, and prospective audit/feedback
• Large health system ASP leadership: $40,000–$70,000/year; chief ASP officer or system-level stewardship director at multi-hospital systems; often combined with academic faculty appointment
• Infection Control Officer (ICO) stipend: $10,000–$30,000/year additional; hospital epidemiology and infection control program medical director; separate role from ASP but often held by the same ID physician at smaller facilities
• Total add-on income: An ID physician with both ASP director and ICO roles at a community hospital can add $25,000–$60,000/year to base clinical compensation through these administrative stipends

NHSC and loan repayment for ID physicians

ID physicians working in underserved communities face the same loan burden as other subspecialists but have more loan repayment options than most, given the overlap between ID care and federally designated shortage areas:

• NHSC Loan Repayment Program: Up to $50,000 (tax-free, 2-year commitment) at NHSC-approved sites; Ryan White HIV clinics, FQHCs with ID providers, and rural critical access hospitals qualify; ID physicians managing HIV and complex infections in underserved communities are strong candidates
• PSLF (Public Service Loan Forgiveness): ID physicians employed by nonprofit hospital systems, academic medical centers, or government health agencies may qualify for PSLF after 10 years of qualifying payments — particularly impactful for academic ID physicians with high loan balances who choose academic over private practice careers
• State-level programs: Several states (Louisiana, Mississippi, rural Mountain West states) offer ID-specific loan repayment for serving in shortage areas with high infectious disease burden (HIV, tuberculosis, hepatitis C, vector-borne diseases)

Geographic variation in ID compensation

• Coastal urban academic centers (NYC, Boston, San Francisco, Chicago): $235,000–$300,000 employed; academic prestige with research supplements; high ID specialist density reduces private practice leverage
• Sun Belt / high-growth markets (FL, TX, AZ): $250,000–$350,000; HIV prevalence, tropical disease overlap, and large hospital systems drive demand; OPAT private practice models more viable in FL/TX commercial payer markets
• Rural and underserved markets: $240,000–$340,000 with NHSC + state supplement; rural hospitals significantly underserved in ID coverage; some critical access hospitals offering $60,000–$90,000 sign-on for ID coverage of antimicrobial stewardship and consultation needs
• Midwest: $230,000–$310,000; academic center ID programs (Mayo Clinic, UChicago, Vanderbilt) provide career anchors; community hospital ID employment more common

What we see at Ava Health

Infectious disease is one of medicine's most undervalued specialties relative to clinical complexity, and we work with ID candidates who are navigating the real compensation gap between employed health system models and the higher-ceiling OPAT private practice or industry alternatives. The stewardship stipend income is frequently overlooked in initial salary negotiations — ID physicians with strong ASP leadership credentials often have leverage to negotiate director stipends worth $25,000–$50,000/year that don't show up in the base salary figure. For ID fellows evaluating their first attending position, we focus on total compensation transparency: base, productivity, stewardship/ICO stipend, and whether the employer has or is building an OPAT program that could generate significant revenue-sharing over the next 3–5 years.

Related: Internal Medicine Physician Salary Guide, Hospitalist Physician Salary Guide, Family Medicine Physician Salary Guide, Physician Assistant Salary Guide.